To what extent will the data of the FLAURA trial that explored first-line use of osimertinib in patients with EGFR-mutated advanced NSCLC change clinical practice? Read more ...
10.10.2017 | Onkologie | Online-Artikel
10.10.2017 | Onkologie | Online-Artikel
To what extent will the data of the FLAURA trial that explored first-line use of osimertinib in patients with EGFR-mutated advanced NSCLC change clinical practice? Read more ...